SCHEMBL19794350

SCHEMBL19794350

C[Si](C)(C)c1cc(-c2ccccc2-c2ccc(-c3ccccn3)cc2)cc(-c2ccccc2-c2ccc(-c3ccccn3)cc2)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.43
CYP2D6 P10635 1/20 0.43
CYP19A1 P11511 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
EDNRB P24530 1/20 0.41
EDNRA P25101 1/20 0.41
KDM4E B2RXH2 2/20 0.41
LMNA P02545 1/20 0.41
POLB P06746 1/20 0.41
CCR1 P32246 1/20 0.41
CCR5 P51681 1/20 0.41
CCR8 P51685 1/20 0.41
METAP1 P53582 1/20 0.41
BLM P54132 1/20 0.41
HIF1A Q16665 1/20 0.41
DOHH Q9BU89 1/20 0.41
P4HTM Q9NXG6 1/20 0.41
PDK2 Q15119 1/20 0.40
CYP2A6 P11509 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19794394 0.88 KDM4E (0.52) CYP1A2CYP2D6CYP19A1CYP2C9CYP2C19
SCHEMBL19794351 0.86 PDK2 (0.41) CYP1A2CYP2D6CYP19A1CYP2C9CYP2C19
SCHEMBL25070279 0.84 TGFBR1 (0.49) CYP1A2CYP2D6CYP19A1CYP2C9CYP2C19
SCHEMBL18015377 0.82 KDM4E (0.49) CYP1A2CYP2D6CYP19A1CYP2C9CYP2C19
SCHEMBL21125566 0.81 CYP2A6 (0.46) CYP1A2CYP2D6CYP19A1CYP2C9CYP2C19
SCHEMBL17800916 0.81 KDM4E (0.52) CYP1A2CYP2D6CYP19A1CYP2C9CYP2C19
SCHEMBL19933595 0.80 GRM5 (0.49) CYP1A2CYP2D6CYP19A1CYP2C9CYP2C19
SCHEMBL21125828 0.80 CHEK2 (0.49) CYP1A2CYP2D6CYP19A1CYP2C9CYP2C19
SCHEMBL19933801 0.80 KDM4E (0.52) CYP1A2CYP2D6CYP19A1CYP2C9CYP2C19
SCHEMBL18573263 0.80 CCR1 (0.53) CYP1A2CYP2D6CYP19A1CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11024815-B2 Metal complexes MERCK PATENT GMBH (DE) 2021-06-01 US disclosed
EP-3254317-B1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2019-07-31 EP disclosed
US-20180026209-A1 Metal Complexes MERCK PATENT GMBH (DE) 2018-01-25 US disclosed
US-20180026209-A1 Metal Complexes MERCK PATENT GMBH (DE) 2018-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11024815-B2 Metal complexes EXOC4, EXOC3, TIMCC CYP1A2 4170/4885CYP2D6 2884/4885CYP19A1 4671/4885
US-20180026209-A1 Metal Complexes AP3M1, AP2M1, SOD1 CYP1A2 3140/4885CYP2D6 2910/4885CYP19A1 3960/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.